Leonteq Securities AG’s Maravai LifeSciences MRVI Stock Holding History

Leonteq Securities AG’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25K	Sell	361 -678	-65%	-$2.93K	﹤0.01%	1137
2026 Q1	$2.94K	Hold	1,039	–	–	﹤0.01%	1148
2025 Q4	$3.38K	Hold	1,039	–	–	﹤0.01%	1285
2025 Q3	$2.98K	Buy	+1,039	New	+$2.65K	﹤0.01%	1200
2023 Q2	–	Sell	-379	Closed	-$5.31K	–	1281
2023 Q1	$5.31K	Sell	379 -31	-8%	-$445	﹤0.01%	1097
2022 Q4	$5.87K	Sell	410 -38	-8%	-$598	﹤0.01%	1120
2022 Q3	$11.4K	Hold	448	–	–	﹤0.01%	1038
2022 Q2	$12.7K	Sell	448 -2,046	-82%	-$64.8K	﹤0.01%	1047
2022 Q1	$88K	Buy	2,494 +2,000	+405%	+$67K	﹤0.01%	757
2021 Q4	$20.7K	Sell	494 -2,506	-84%	-$102K	﹤0.01%	1039
2021 Q3	$147K	Hold	3,000	–	–	0.01%	646
2021 Q2	$125K	Hold	3,000	–	–	0.01%	674
2021 Q1	$107K	Buy	3,000 +1,000	+50%	+$33.1K	0.01%	667
2020 Q4	$56.1K	Buy	+2,000	New	+$55.7K	﹤0.01%	763

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Leonteq Securities AG's MRVI Position: Q2 2026 in Review

Leonteq Securities AG reduced its Maravai LifeSciences (MRVI) stake by 65% in Q2 2026, selling an estimated $2.93K and leaving 361 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Leonteq Securities AG first reported a position in MRVI in Q4 2020 and has held it in 14 quarters since. The position peaked at $147K in Q3 2021. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Leonteq Securities AG held 361 shares of Maravai LifeSciences worth $2.25K as of Q2 2026.
Leonteq Securities AG sold 678 Maravai LifeSciences shares in Q2 2026, an estimated $2.93K.
Maravai LifeSciences made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1137 holding.
Leonteq Securities AG first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 14 quarters since.
Leonteq Securities AG's Maravai LifeSciences position peaked at $147K in Q3 2021.
177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.